{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T08:54:32Z","timestamp":1789808072927,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.thromres.2008.02.010","type":"journal-article","created":{"date-parts":[[2008,4,19]],"date-time":"2008-04-19T13:18:19Z","timestamp":1208611099000},"page":"854-860","source":"Crossref","is-referenced-by-count":22,"title":["Plasminogen activator inhibitor-1 (PAI-1) 4G\/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression"],"prefix":"10.1016","volume":"122","author":[{"given":"Luis A.","family":"Ram\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Gilabert\u2013Estell\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Cos\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Gilabert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Espa\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remedios","family":"Castell\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melitina","family":"Chirivella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Romeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amparo","family":"Estell\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2008.02.010_bib1","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0015-0282(98)00285-4","article-title":"Fibrinolytic factors in endometriotic tissue, endometrium, peritoneal fluid, and plasma from women with endometriosis and in endometrium and peritoneal fluid from healthy women","volume":"70","author":"Bruse","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.thromres.2008.02.010_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1196\/annals.1290.025","article-title":"Urokinase\u2013type plasminogen activator and insulin\u2013like growth factor\u2013binding protein 3 mRNA expression in endometriotic lesions and eutopic endometrium: Implications for the pathophysiology of endometriosis","volume":"997","author":"Lembessis","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.thromres.2008.02.010_bib3","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/humrep\/deg300","article-title":"Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis","volume":"18","author":"Gilabert\u2013Estell\u00e9s","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.thromres.2008.02.010_bib4","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1093\/humrep\/dem149","article-title":"Expression of angiogenic factors in endometriosis: Its relation to fibrinolytic and metalloproteinase (MMP) systems","volume":"22","author":"Gilabert\u2013Estell\u00e9s","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.thromres.2008.02.010_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0268-9499(91)90001-K","article-title":"Regulation of PAI-1 gene expression","volume":"5","author":"Loskutoff","year":"1991","journal-title":"Fibrinolysis"},{"key":"10.1016\/j.thromres.2008.02.010_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0303-7207(90)90164-4","article-title":"Plasminogen activator inhibitors: Hormonally regulated serpins","volume":"68","author":"Andreasen","year":"1990","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.thromres.2008.02.010_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/blood.V84.1.143.143","article-title":"Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and\/or intrauterine fetal growth retardation","volume":"84","author":"Estell\u00e9s","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2008.02.010_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1749-6632.2001.tb03796.x","article-title":"Endometrial quality in infertile women with endometriosis","volume":"943","author":"Pellicer","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.thromres.2008.02.010_bib9","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/clinchem\/48.8.1288","article-title":"Quantitative real\u2013time reverse transcription\u2013PCR assay for urokinase plasminogen activator, plasminogen activator Inhibitor type 1 (PAI-1) and tissue metalloproteinase inhibitor type 1 (TIMP-1) gene expression in primary breast cancer","volume":"48","author":"Castell\u00f3","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.thromres.2008.02.010_bib10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000055086","article-title":"Clinical relevance of the plasminogen activator inhibitor type 1, a multifaceted proteolytic factor","volume":"24","author":"Harbeck","year":"2001","journal-title":"Onkologie"},{"key":"10.1016\/j.thromres.2008.02.010_bib11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1055\/s-0038-1646997","article-title":"Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2","volume":"60","author":"Alessi","year":"1988","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2008.02.010_bib12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0038-1646174","article-title":"Regulation of PAI-1 gene expression in vivo","volume":"70","author":"Loskutoff","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2008.02.010_bib13","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/01.ATV.17.5.851","article-title":"Five frequent polymorphisms of the PAI-1 gene: Lack of association between genotypes, PAI activity, and triglyceride levels in a healthy population","volume":"17","author":"Henry","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2008.02.010_bib14","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1073\/pnas.92.6.1851","article-title":"Allele\u2013specific increase in basal transcription of the plasminogen\u2013activator inhibitor 1 gene is associated with myocardial infarction","volume":"92","author":"Eriksson","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.thromres.2008.02.010_bib15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cardiores.2004.03.023","article-title":"Influence of the 4G\/5G PAI-1 genotype on angiotensin II-stimulated human endothelial cells and in patients with hypertension","volume":"63","author":"Roncal","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.thromres.2008.02.010_bib16","doi-asserted-by":"crossref","first-page":"10739","DOI":"10.1016\/S0021-9258(18)82047-6","article-title":"The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells","volume":"268","author":"Dawson","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2008.02.010_bib17","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1055\/s-0037-1614516","article-title":"Plasminogen activator inhibitor-1 (PAI-1) promoter 4G\/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease","volume":"81","author":"Grancha","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2008.02.010_bib18","article-title":"Plasminogen activator inhibitor-1 levels in severe and morbid obesity. Effect of weight loss and influence of 4G\/5G polymorphism","author":"Sol\u00e1","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2008.02.010_bib19","article-title":"The effect of the plasminogen activator inhibitor-1 4G\/5G polymorphism on the thrombotic risk","author":"Tsantes","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2008.02.010_bib20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.thromres.2005.03.025","article-title":"Plasminogen activator inhibitor-1 (PAI-1) 4G\/5G polymorphism in human breast cancer and its association with tissue PAI-1 levels and severity tumor grade","volume":"117","author":"Castell\u00f3","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2008.02.010_bib21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/01.AOG.0000220517.53892.0a","article-title":"Genetic polymorphism in the fibrinolytic system and endometriosis","volume":"108","author":"Bedaiwy","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.thromres.2008.02.010_bib22","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0015-0282(97)81391-X","article-title":"Revised American Society for Reproductive Medicine Classification of endometriosis: 1996","volume":"67","author":"American Society for Reproductive Medicine","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.thromres.2008.02.010_bib23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/humrep\/deh571","article-title":"mRNA quantitative analysis of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis using real\u2013time reverse transcription\u2013PCR assay","volume":"20","author":"Ram\u00f3n","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.thromres.2008.02.010_bib24","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.thromres.2006.12.016","article-title":"Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer","volume":"120","author":"Castell\u00f3","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2008.02.010_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/molehr\/gah033","article-title":"In situ localization of mRNA for the fibrinolytic factors uPA, PAI-1 and uPAR in endometriotic and endometrial tissue","volume":"10","author":"Bruse","year":"2004","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.thromres.2008.02.010_bib26","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.2741\/1609","article-title":"Plasminogen activators and plasminogen activator inhibitors in endometriosis","volume":"10","author":"Gilabert\u2013Estell\u00e9s","year":"2005","journal-title":"Front Biosci"},{"key":"10.1016\/j.thromres.2008.02.010_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000093556","article-title":"Expression of fibrinolytic components in endometriosis","volume":"35","author":"Gilabert\u2013Estell\u00e9s","year":"2006","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.thromres.2008.02.010_bib28","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.fertnstert.2004.06.060","article-title":"A role for the fibrinolytic system in postsurgical adhesion formation","volume":"83","author":"Hellebrekers","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.thromres.2008.02.010_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1749-6632.2001.tb03797.x","article-title":"Endometrial anomalies in women with endometriosis","volume":"943","author":"Sharpe\u2013Timms","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.thromres.2008.02.010_bib30","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0895-4356(03)00052-0","article-title":"Prospective study of fibrinolytic markers and venous thromboembolism","volume":"56","author":"Folsom","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.thromres.2008.02.010_bib31","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1111\/j.1538-7836.2005.01591.x","article-title":"Role of angiotensin\u2013converting enzyme insertion\/deletion and plasminogen activator inhibitor-1 4G\/5G gene polymorphisms in retinal vein occlusion","volume":"3","author":"Mattes","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2008.02.010_bib32","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1046\/j.1365-2141.2000.02321.x","article-title":"PAI-1 promoter 4G\/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects","volume":"111","author":"Segu\u00ed","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2008.02.010_bib33","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1161\/01.STR.0000174485.10277.24","article-title":"Plasminogen activator inhibitor-1 4G\/5G polymorphism and risk of stroke: Replicated findings in two nested case\u2013control studies based on independent cohorts","volume":"36","author":"Wiklund","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2008.02.010_bib34","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humupd\/4.5.741","article-title":"Endometriotic disease: The role of peritoneal fluid","volume":"4","author":"Koninckx","year":"1998","journal-title":"Hum Reprod Update"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384808000777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384808000777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T15:33:26Z","timestamp":1631115206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384808000777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0049384808000777"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2008.02.010","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}